Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA242297
Max Phase: Preclinical
Molecular Formula: C16H24N2O
Molecular Weight: 260.38
Molecule Type: Small molecule
Associated Items:
ID: ALA242297
Max Phase: Preclinical
Molecular Formula: C16H24N2O
Molecular Weight: 260.38
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CO[C@@H]1CCC2CN(C)C1CN2Cc1ccccc1
Standard InChI: InChI=1S/C16H24N2O/c1-17-11-14-8-9-16(19-2)15(17)12-18(14)10-13-6-4-3-5-7-13/h3-7,14-16H,8-12H2,1-2H3/t14?,15?,16-/m1/s1
Standard InChI Key: IVZQYZAGDIJTME-UYSNPLJNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 260.38 | Molecular Weight (Monoisotopic): 260.1889 | AlogP: 1.98 | #Rotatable Bonds: 3 |
Polar Surface Area: 15.71 | Molecular Species: BASE | HBA: 3 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.59 | CX LogP: 2.30 | CX LogD: 1.08 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.83 | Np Likeness Score: 0.19 |
1. Weigl M, Wünsch B.. (2007) Synthesis of bridged piperazines with sigma receptor affinity., 42 (10): [PMID:17420073] [10.1016/j.ejmech.2007.02.005] |
Source(1):